The evolving role of multimodal imaging, artificial intelligence and radiomics in the radiologic assessment of immune related adverse events

IF 1.5 4区医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Clinical Imaging Pub Date : 2025-07-28 DOI:10.1016/j.clinimag.2025.110571

Jeeban P. Das , Hong Y. Ma , Dorine DeJong , Conor Prendergast , Alireza Baniasadi , Brian Braumuller , Anna Giarratana , Saeid Khonji , Jacienta Paily , Parnian Shobeiri , Randy Yeh , Laurent Dercle , Kathleen M. Capaccione

{"title":"The evolving role of multimodal imaging, artificial intelligence and radiomics in the radiologic assessment of immune related adverse events","authors":"Jeeban P. Das , Hong Y. Ma , Dorine DeJong , Conor Prendergast , Alireza Baniasadi , Brian Braumuller , Anna Giarratana , Saeid Khonji , Jacienta Paily , Parnian Shobeiri , Randy Yeh , Laurent Dercle , Kathleen M. Capaccione","doi":"10.1016/j.clinimag.2025.110571","DOIUrl":null,"url":null,"abstract":"<div><div>Immunotherapy, in particular checkpoint blockade, has revolutionized the treatment of many advanced cancers. Imaging plays a critical role in assessing both treatment response and the development of immune toxicities. Both conventional imaging and molecular imaging techniques can be used to evaluate multisystemic immune related adverse events (irAEs), including thoracic, abdominal and neurologic irAEs. As artificial intelligence (AI) proliferates in medical imaging, radiologic assessment of irAEs will become more efficient, improving the diagnosis, prognosis, and management of patients affected by immune-related toxicities. This review addresses some of the advancements in medical imaging including the potential future role of radiomics in evaluating irAEs, which may facilitate clinical decision-making and improvements in patient care.</div></div>","PeriodicalId":50680,"journal":{"name":"Clinical Imaging","volume":"125 ","pages":"Article 110571"},"PeriodicalIF":1.5000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Imaging","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0899707125001718","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

Abstract

Immunotherapy, in particular checkpoint blockade, has revolutionized the treatment of many advanced cancers. Imaging plays a critical role in assessing both treatment response and the development of immune toxicities. Both conventional imaging and molecular imaging techniques can be used to evaluate multisystemic immune related adverse events (irAEs), including thoracic, abdominal and neurologic irAEs. As artificial intelligence (AI) proliferates in medical imaging, radiologic assessment of irAEs will become more efficient, improving the diagnosis, prognosis, and management of patients affected by immune-related toxicities. This review addresses some of the advancements in medical imaging including the potential future role of radiomics in evaluating irAEs, which may facilitate clinical decision-making and improvements in patient care.

查看原文本刊更多论文

多模态成像、人工智能和放射组学在免疫相关不良事件放射学评估中的演变作用

免疫疗法，特别是检查点阻断，已经彻底改变了许多晚期癌症的治疗。成像在评估治疗反应和免疫毒性的发展中起着关键作用。常规影像学和分子影像学技术均可用于评估多系统免疫相关不良事件（irAEs），包括胸部、腹部和神经系统的irAEs。随着人工智能（AI）在医学成像领域的普及，对irae的放射学评估将变得更加有效，从而改善受免疫相关毒性影响患者的诊断、预后和管理。本文综述了医学影像学的一些进展，包括放射组学在评估irae中的潜在未来作用，这可能有助于临床决策和改善患者护理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Imaging 医学-核医学

CiteScore

4.60

自引率

0.00%

发文量

265

审稿时长

35 days

期刊介绍： The mission of Clinical Imaging is to publish, in a timely manner, the very best radiology research from the United States and around the world with special attention to the impact of medical imaging on patient care. The journal''s publications cover all imaging modalities, radiology issues related to patients, policy and practice improvements, and clinically-oriented imaging physics and informatics. The journal is a valuable resource for practicing radiologists, radiologists-in-training and other clinicians with an interest in imaging. Papers are carefully peer-reviewed and selected by our experienced subject editors who are leading experts spanning the range of imaging sub-specialties, which include: -Body Imaging- Breast Imaging- Cardiothoracic Imaging- Imaging Physics and Informatics- Molecular Imaging and Nuclear Medicine- Musculoskeletal and Emergency Imaging- Neuroradiology- Practice, Policy & Education- Pediatric Imaging- Vascular and Interventional Radiology